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Abstract
Laminitis is a common and debilitating disease affecting horses and ponies. It often leads to the demise of the
animal. Energy deficiency is suspected to entrain the disruption of the hemidesmosomes leading to the failure of the
dermal-epidermal interface. The aim of this study was to measure the muscle mitochondrial function by high
resolution respirometry. Muscle micro-biopsies were obtained from 11 horses affected by acute metabolic laminitis,
6 horses affected by acute laminitis resulting from a systemic inflammation response syndrome and 28 healthy
horses distributed in 2 control groups: 17 horses with a body condition score [BSC, ranging from 0 (emaciated) to 5
(obese)] of 2 to 3 and 11 horses with a BSC of 4 to 5. During the acute phase of laminitis, a significant reduction of
the muscle mitochondrial respiration was observed. The muscle mitochondrial dysfunction occurred independently of
the etiology (metabolic disorder or systemic inflammation) leading to laminitis. The reduction of the oxidative
phosphorylation and of the maximal respiratory capacity (after uncoupling) may induce depletion of the cell’s ATP
content. If the same mitochondrial alteration occurs in the foot lamina, mitochondria targeting should be considered
for the future, not only to better understand the physiopathology of the disease but also to maintain and to support
the mitochondrial function before reaching the « mitochondrial dysfunction threshold » that may lead to the failure of
the dermal-epidermal interface.
Keywords: Horse; Laminitis; Mitochondria; Electron transfer
system; Energy metabolism dysfunction; Oxidative phosphorylation;
Inflammation; Reactive oxygen species
Introduction
Laminitis is a common and debilitating disease affecting horses and
ponies. In its severe form it may necessitate the demise of the animal
[1]. Laminitis is characterized by the failure of the laminar dermal-
epidermal interface resulting in severe lameness.
Despite ongoing research, laminitis remains a severely damaging
condition of which the physiopathology is poorly understood.
Currently, the primary hypotheses explaining the pathogenesis of
acute laminitis include inflammation and extracellular matrix
degradation, metabolic abnormalities and endothelial/vascular
dysfunction [2].
Recent epidemiological studies have identified a variety of risk
factors for the development of laminitis, such as weight gain, season of
the year, hours of sunshine on the pasture, recent access to grass, box
rest, owner-reported history of laminitis, lameness or foot-soreness
after shoeing/trimming, and existing endocrinopathic and metabolic
disease [3,4]. Endotoxemia and sepsis have been recognized in a
follow-up of hospitalized horses as the only significant risk factor for
developing laminitis [5]. Inflammation seems to play a central role in
the pathogenesis of laminitis, and this independently of the key factors
involved [6]. In cases of sepsis, local infection is accompanied by
systemic neutrophil activation. Systemic neutrophil activation is also
encountered in equine laminitis, as demonstrated by the up-regulation
of cytokine expression, the dynamic changes in blood neutrophil
phenotype, the formation of neutrophil-platelet aggregates and the
infiltration of inflammatory cells [7-10]. However, other factors than
endotoxins are responsible for the changes in laminar tissue gene
expression that occurs during the development of acute equine
laminitis [11,12].
The systemic and the local inflammatory responses and the release
of cytokines, enzymes such as myeloperoxidase or elastase, have
largely been described in previously developed laminitis models such
as Carbohydrate Overload (CHO), Oligofructose (OF) and Black
Walnut Heartwood Extract (BWHE). This underlines the major role of
neutrophil activation [13-16]. The hypothesis of an involvement of
neutrophil-mediated mitochondrial dysfunction was previously
observed in muscle micro-biopsies from horses after strenuous
exercise [17]. Moreover, in cultured muscle cell lines, it was
demonstrated that the potent neutrophil-derived oxidative enzyme
myeloperoxidase could enter the cell and disturb the electron transfer
system resulting in altered ATP production [18].
Laminitis has also been associated with horses diagnosed with
metabolic disorders, such as obesity, pituitary pars intermedia
dysfunction or equine metabolic syndrome. The primary characteristic
of these pathologies is the development of insulin resistance,
characterized by hyperinsulinemia with eu- or hyperglycemia and
subsequent chronic pro-inflammatory state [19,20]. While several
aspects of the relationship between insulin resistance and laminitis
have been investigated, the underlying pathological pathway has not
yet been identified. An experimental model of laminitis showed that
healthy Standard bred horses subjected to prolonged
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hyperinsulinaemia develops laminitis within 48 h [21]. Furthermore,
natural cases of equine endocrinopathic laminitis are clearly associated
with hyperinsulinemia [22].
Recently, Gauff et al. showed that short-term hyperinsulinaemia in
the isolated, perfused extracorporeal equine digit leads to a marked
increase in vascular resistance and an increase in endothelin-1
expression [23].
Several studies confirmed a mitochondrial dysfunction in human
patients suffering from metabolic disorders related to insulin
resistance [24,25]. Indeed, glucose and lipid metabolism are largely
dependent on energy generated by mitochondria and several
experimental protocols have demonstrated an effect of
hyperinsulinemia on mitochondrial function [26,27].
In this work, we hypothesized that muscle mitochondrial function
is altered in horses suffering from laminitis. As the mitochondrial
function is frequently studied in muscles, we decided to investigate
this using High-Resolution Respirometry (HRR) on muscular micro-
biopsies [28]. High-resolution respirometry allows the determination
of Oxidative Phosphorylation (OXPHOS) and Electron Transfer
System (ETS) capacities in small samples (2 mg) of permeabilized
tissues [28]. Multiple Substrate-Uncoupler-Inhibitor Titration (SUIT)
protocols have been recently developed to screen the mitochondrial
function of equine muscles [29]. In the present study, this technique
was used to study mitochondrial function in laminitis affected horses.
Material and Method
Horses
All procedures were approved by the Animal Ethic Commission of
the University of Liege (agreement n°07–629) and informed owner
consent was obtained when appropriate. Muscle micro-biopsy is
performed on healthy horses (n=28) and on clinical cases of acute
laminitis observed in the Equine Clinic of the University of Liege
between 2011 and 2013 (n=17). The Body Condition Score (BSC) was
determined based on palpation of fat deposits in five specific body
areas and by visual assessment of seven anatomic sites [30]. Each
evaluation receives a notation and the average defines the BSC ranging
from 0 (emaciated) to 5 (obese). All the horses were categorized in two
groups: score 0 for a BSC between 2 to 3 (n=23) and score 1 for a BSC
between 4 to 5 (n=22).
The healthy horses were divided in two control groups: control
obese (contob) and control non obese (cont fit). Muscle micro-
biopsies were obtained from 2 distinct groups of acute laminitic
horses. The first group was assigned as “metabolic laminitis” (Met
Lam). These horses were showing symptoms of acute laminitis and
were diagnosed as suffering from metabolic syndrome [31]. The
second group was assigned as “inflammatory laminitis” (Infl Lam) and
was composed of horses affected by acute laminitis resulting from a
systemic inflammatory response syndrome.
So, 4 groups of horses were established: healthy non obese (Cont fit:
n=17), healthy obese (Contob: n=11), laminitic obese (Met Lam, n=11)
and laminitic non obese (Infl Lam: n=6). All data obtained from the
horses are reported in the Table 1.
Muscle micro-biopsy
Approximately 20 mg of muscle have been collected from the
triceps brachii muscle using a 14 G biopsy needle mounted on an
automatic instrument as earlier described (Pro-Mag™ Ultra Biopsy
Instrument, Angiotech, Gainesville, Fl, USA) [29]. Briefly, the
sampling site was shaved and desensitized by subcutaneous injection
of 0.5 ml of mepivacain (Scandicaine 2%, AstraZeneca, Brussels,
Belgium), and aseptically prepared.
Muscle micro-biopsy specimens were taken at 40 mm depth in the
long head of the triceps brachii through a skin incision. Two to three
muscle samples were obtained via the same skin opening and
transferred immediately into ice-cold relaxing solution BIOPS
containing 10 mM CaK2-EGTA, 7.23 mM K2-EGTA, 20 mM
imidazole, 20 mM taurine, 50 mM K-MES, 0.5 mM dithiothreitol, 6.56
mM MgCl2, 5.77 mM ATP and 15 mM phosphocreatine adjusted to
pH 7.1. Fibers were kept at 4°C until further preparation.
Age Weight BCS CI CI+II ETSmax CII
Metabolic laminitis (EMS) (Years) (Kg) (/5) (pmol oxygen/s* mg muscle)
HoM1 12 625 4 34.46 75.5 83.38 58.28
HoM2 17 406 4 36.66 96.76 111.72 75.94
HoM3 12 475 5 42.09 67.75 91.42 53.52
HoM4 16 590 4 55.08 96.56 129.90 80.99
HoM5 23 310 4 36.34 64.87 82.43 54.56
HoM6 11 NA 4 56.05 89.07 138.06 73.58
HoM7 11 NA 4 47.35 94.23 127.73 82.34
HoM8 13 683 5 30.69 46.80 72.84 43.86
HoM9 4 650 4 29.25 45.16 62.45 37.25
HoM10 16 620 4 49.31 78.72 96.69 56.93
HoM11 8 530 4 39.28 61.94 79.57 47.09
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mean (± SD) 13 ± 4 522 ± 122 4-5 45.73 ± 17.11 82.38 ± 33.23 108.65 ± 44.58 68.31 ± 31.17
Control obese (n=11)        
Mean (± SD) 12 ± 5 nd 4-5 51.60 ± 13.98 102.76 ± 23.45 119.79 ± 24.27 81.85 ± 16.79
Inflammatory laminitis        
HoI1 10 625 3 27.00 65.50 70.40 54.60
HoI2 2 470 2 52.37 77.78 103.16 56.21
Hol3 3 700 3 27.02 48.17 73.15 42.67
Hol4  21 550 3 48.64 71.50 97.82 56.27
Hol5 11 580 2 78.28 118.38 151.27 78.80
Hol6 4 700 3 35.36 67.31 87.07 57.05
mean (± SD) 9 ± 7 604 ± 89 2-3 44.78 ± 19.57 74.77 ± 23.54 97.15 ± 29.52 57.60 ± 11.70
Control non obese (n=17)        
mean (±SD) 8±3 nd 2-3 58.79 ± 12.6 116.37 ± 18.9  139.66 ± 19.38  96.13 ± 12.82
Table 1: Characteristics of horses used in the study and their respiratory parameters from substrate-uncoupler-inhibitor titration protocol 1
(SUIT1) applied on equine permeabilized muscle fibers of triceps brachii: Complex I (CI), Complex I + II (CI+II), maximal respiratory
(ETSmax) and Complex II (CII) capacities.
High resolution respirometry
Connective tissue and other visible tissues than muscle were
removed and muscle fibers were mechanically separated using two
pairs of forceps with sharp tips. Complete permeabilization of the
plasma membrane was obtained by gentle agitation for 30 min at 4°C
in 2 ml of BIOPS solution containing 50 µg/ml saponin. The fiber
bundles were rinsed by agitation for 10 min in ice-cold mitochondrial
respiration medium (MiR05; 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-
lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM Hepes, 110 mM
sucrose and 1 g/l BSA essentially fatty acid free) adjusted to pH 7.1.
The permeabilized muscle fibers (Pfi) were immediately used for HRR.
One to 2.5 mg (Microbalance; Mettler Toledo, Zaventem, Belgium)
of Pfi were added to each Oxygraph-2k chamber (Oroboros
Instruments, Innsbruck, Austria) containing 2 ml of MiR05 at 37.0°C.
Oxygen concentration (µM), and oxygen flux per muscle mass (pmol
O2/sec*mg) were recorded online using DatLab software (Oroboros
Instruments, Innsbruck, Austria). After calibration of the oxygen
sensors at air saturation, a few ml of oxygen were introduced into the
gas phase above the stirred aqueous phase in the partially closed
chambers to reach a concentration of 500 µM O2. During SUIT
protocols (about 1 hour), the oxygen level in the chambers was
maintained between 200 and 500 µM O2 to avoid any oxygen
limitation of respiration. As recommended, respiratory flux was
corrected on-line for instrumental background, determined at
experimental oxygen levels.
To obtain extended information on coupling and substrate control
parameters, the SUIT protocol was applied on Pfi. In this protocol,
electron flow through complex I (CI) was supported by the NADH-
linked substrates glutamate + malate (GM; 10 and 2 mM) with
subsequent addition of ADP (2.5 mM). ADP-stimulated respiration
represents OXPHOS capacity (State P). Then, we added succinate (S;
10 mM) for convergent electron flow through complex I and II (CI+II)
into the Q-junction (supported by GMS). The capacity of the
phosphorylation system (adenine nucleotide translocase, inorganic
phosphate transporter, and ATP synthase) may limit OXPHOS
capacity with an apparent excess capacity of the electron transport
system (ETS) over the phosphorylation system [28]. This was tested by
stepwise addition of the uncoupler FCCP (Carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone; 0.05 µM, followed by several
0.025 µM additions (steps) until maximal oxygen flux was reached),
obtaining the ETS capacity, ETS max, with convergent electron flow
through CI+II. Electron input into the Q-junction through complex II
(CII) alone was subsequently induced by inhibition of CI by rotenone
(Rot; 0.5 µM). Finally, residual oxygen consumption (ROX) was
obtained by addition of antimycinA (2.5 µM) to block electron transfer
through complex III (CIII]). Oxygen fluxes were corrected by
subtracting ROX from each measured mitochondrial steady-state.
Integrity of the outer mitochondrial membrane was tested by
adding 10 µM cytochrome c after ADP in the presence of substrates
feeding electrons into CI. Injury of the outer mitochondrial membrane
leads to loss of cytochrome c from the mitochondria, and to significant
stimulation of respiration following addition of exogenous
cytochrome c to the respiration medium.
Oxygen flux was expressed as tissue mass-specific respiration (per
mg), or as Flux Control Ratios (FCR), with internal normalization for
maximum ETS capacity.
Statistical analysis
Respirometry measurements were performed at least in duplicate
for each protocol. The oxygen flux and FCR are presented as mean ±
SD for the 4 groups, i.e. Cont fit, Contob, Met Lam and Infl Lam. A
levene’s test was used for all the dependent variables to test the
equality of variance then a two-way analysis of variance was used for
each dependent variable taking into account two qualitative factors:
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score and laminitis. Furthermore, a Student T test were used when the
variances are equal to compare the mean oxygen flux values of CI, CI
+II, ETSmax and CII alone between the Cont fit group and the Infl lam
group and between the Contob group and the Met lam group. The
BSC were compared between the groups by a Mann-Whitney test. A
value of p<0.05 was considered as level of significance (MedCalc;
MedCalc Software, Version 12.7.7.; Ostend, Belgium).
Results
The comparison of the BSC measured in each group showed
significant differences between the Cont fit and the Contob groups
and between the Infl Lam and the Met Lam groups.
The figure 1 illustrates oxygraphic records obtained on one healthy
horse and two laminitic horses (Metabolic Laminitis, Inflammatory
Laminitis).
Figure 1: Example of HRR curves. Illustration of the curves
obtained via the Oroboros oxygraph software [DatLab 4.0,
OROBOROS DatLab software, Innsbruck, Austria] for one horse of
each group [Control, Metabolic laminitis and Inflammatory
laminitis]. The blue line represents the oxygen concentration in the
medium [pmol/ml] and the red line represents the slope of the blue
line, thus the oxygen flux expressed as tissue mass-specific
respiration [pmol oxygen/sec*mg of permeabilized fibers]. The
vertical lines represent the different substrates/inhibitors/
uncouplers added to the oxygraph chambers. The black rectangles
represent the selected time laps during which CI [Complex I], CI +
II [Complex I and 2], maximal respiratory [ETSmax] and CII
[Complex II] capacities were calculated by DatLab™.
The Cont fit horses showed a mean tissue mass-specific respiration
(per mg of muscle) of 58.79 (± 12.56) pmol O2/sec with CI substrates
(Table 1). Their maximal OXPHOS and ETS capacities with
physiological CI+II substrates were 116.37 (± 18.89) and 139.65
(±19.38) pmol O2/sec respectively. For the CII alone, the tissue mass-
specific respiration was 96.13 (± 12.82) pmol O2/sec. The ContOb
horses showed a mean tissue mass-specific respiration (per mg of
muscle) of 51.60 (±13.98) pmol O2/sec with CI substrates (Table 1).
Their maximal OXPHOS and ETS capacities with physiological CI+II
substrates were 102.76 (± 23.46) and 119.76 (± 24.27) pmol O2/sec
respectively. For the CII alone, the tissue mass-specific respiration was
81.85 (± 16.79) pmol O2/sec. Compared to the cont fit horses, the
contob horses showed a significant decrease of ETS capacities and CII
alone.
The two-way analysis of variance to test the effect of the two
qualitative factors (Score and laminitis) revealed that any dependent
variable was significantly affected by the body score index. However, a
significant effect of the factor “laminitis” was observed for CI, CI+II,
ETS capacities, CII alone. Otherwise, when FCR was applied only the
CII was significantly different between the horses affected or not by
the disease. The T-test analysis comparing the ContOb group to the
Met Lam group showed a significant decrease of the oxygen flux for CI
+CII and CII alone. Compared to Cont Fit horses, the Infl Lam group
showed a significant decrease of the oxygen flux for CI+CII, ETS
capacities and CII alone.
Figure 2: Tissue mass-specific respirations. Tissue mass-specific
respirations [mean ± SD of oxygen flux per mg of muscle; pmol
O2*sec-1*mg-1] of control non obese [Cont fit], control obese
[ContOb], metabolic laminitis [Met Lam] and inflammatory
laminitis [Infl Lam] horses. CI: Oxygen flux via mitochondrial
complex I; CI+II: Oxygen flux via mitochondrial complex I and II;
ETS: maximal respiratory capacity after total uncoupling with
carbonyl cyanide 4-[trifluoromethoxy] phenylhydrazone; CII:
Oxygen flux via mitochondrial complex II alone. * p<0.05 Inf Lam
vs. Control non Ob or Met Lam vs. ControlOb
The SUIT protocol allowed us to also establish the FCR for each
group of horses (Figure 3). Cont fit horses used 41.68 (± 5.08) % and
68.99 (± 7.21) % of their maximal ETS capacity via respectively CI and
CII alone. When substrates for CI and CII are available (CI+II), they
used 83.45 (± 9.46) % of their maximal ETS capacity. Similar values are
observed in the control obese group (CI: 43.11 ± 6.9; CII: 68.87 ± 9.13;
CI+CII: 86.16 ± 12.32). The CI+CII values represented the maximal
proportion of their respiratory capacity that mitochondria are
effectively able to use for producing ATP, and thus, energy.
Notwithstanding, via CI, Met Lam or Infl Lam horses did not use a
significant greater proportion of their respective maximal ETS capacity
than Control horses. On the contrary, the 2 pathological groups used a
significant lower part of their maximal ETS capacity via CII: 61.72 (±
4.85) % for Met Lam and only 59.29 (± 9.33) % for Infl Lam. However,
when regarding the proportion of ETS max used via CI+II, a significant
reduction was only observed for Met Lam horses as compared to the
Contob group.Thus, they were able to use only 75.94 (± 8.1) % of their
maximal respiratory capacity. A similar non-significant trend was also
observed in the Infl Lam group.
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Figure 3: Flux control ratios. Flux control ratios [mean ± SD] of
control non obese, control obese, metabolic laminitis [Met Lam]
and inflammatory laminitis [Infl Lam] horses, standardized for
their respective maximal respiratory capacities [ETSmax = 100%
for each experimental group]. CI: part of ETSmax used via
mitochondrial complex I; CI+II: part of ETSmax used via
mitochondrial complex I and II; ETS max: maximal respiratory
capacity; CII: part of ETSmax used via mitochondrial complex II.*
p<0.05 Met Lam vs. ContOb or Infl Lam vs. Cont fit
Discussion
The results of the present study confirm the hypothesis that
significant reduction of muscle mitochondrial respiration is observed
during the acute phase of laminitis. The reduction of OXPHOS may
result in a depletion of the cells’ ATP content. This is especially true if
the glycolytic pathway cannot compensate for the deficient ATP.
Laminitis is considered as a systemic disease with clinical signs
localized in the foot. Even where mitochondrial dysfunction has not
been demonstrated in the foot, energy deficiency has been suggested as
an explanation for the disruption of the hemidesmosomes leading to
the failure of the dermal-epidermal interface [32].
An energy deficit can arise either from a reduction in the supply of
oxygen and/or nutrients or from impaired mitochondrial function in
itself. The HRR procedure with supplemented substrates (glutamate,
malate and ADP) performed on permeabilized muscle micro-biopsies
to measure OXPHOS and ETS capacities demonstrated that the
mitochondrial respiratory chain is clearly affected.
Several authors consider that the OXPHOS and maximal ETS
capacity are influenced by the physical activity and the body mass
index of the subject [33,34]. Votion et al. showed lower respirometric
parameters in overweight and untrained horses than in competition
horses [29]. Thus, two groups of control horses were included in this
study with the aim to clearly identify the effects of a high BSC. The two
way analysis of variance to test the BSC was not significant and the
interaction between the two factors (BSC and laminitis) was not
significant for each tested variables. Nevertheless, using the T-test, we
observed a significant reduction of maximal ETS capacity and CII
alone in the obese horses compared to the horses with a normal BSC.
But when oxygen flux was expressed as tissue mass-specific respiration
(per mg), or as flux control ratios, with internal normalization for
maximum ETS capacity (FCR), no significant difference were observed
between the two control groups. Matching of breed and level of
training was realized for the normal BSC groups, in order to obtain an
adequate control group for the inflammatory laminitis group.
Nevertheless, the oxygen flux for CI+CII, CII alone were
significantly reduced in both acute laminitis groups compared to
healthy horses and maximal ETS capacity especially in the Infl Lam
group.
The differences between the laminitis horses and the control horses
having a high BSC could be related to a certain level of metabolic
syndrome. Indeed, equine metabolic syndrome is characterized by
obesity and local adiposity coupled with evidence of recurrent
laminitis [35]. These authors observed that a marked increase in
neutrophil reactive oxygen species production upon phagocytosis was
observed in horses with metabolic syndrome that was closely
correlated to the blood insulin concentration. Insulin resistance is
currently observed in horses suffering from metabolic syndrome.
Based on the results of this study, it would have been interesting to
dose insulin in our patients. However, to confirm insulin resistance, it
is also necessary to show abnormal glycemic and insulinemic
responses to oral or IV glucose and/or insulin challenges. These tests
would have been ethically unacceptable on clinical cases, taking into
account the risks of aggravating the disease.
When internal normalization for maximum ETS capacity (FCR)
was applied, we observed clearly that the complex II was principally
affected. Mitochondrial complex II oxidizes succinate to fumarate as
part of the Krebs cycle and reduces ubiquinone in the electron
transport system. Succinate-driven oxidation via complex II may
contribute significantly to high rates of production of Reactive Oxygen
Species (ROS) by mitochondria [36,37].
A Complex II defect was accompanied by a biphasic increase of
ROS and concurrent glutathione oxidation, both concomitant to a
decrease of the ATP cellular level [38]. High ROS generation is
considered as a key point in human patients affected by metabolic
syndrome and insulin resistance [39]. The implication of ROS in the
pathogenesis of laminitis has already been suggested [40,41].
Moreover, activated neutrophils generate ROS and release oxidant
enzyme such as myeloperoxidase and proteases including elastase and
matrix metalloproteinase 9. In a model of muscle cells in culture, it
was demonstrated that myeloperoxidase increased significantly the
ROS amount generated by anoxia and reoxygenation cycles [42]. Thus,
the production of ROS in lamina could be explained by neutrophil
activation with the presence of myeloperoxidase in the lamina and/or
by the mitochondrial dysfunction.
In this study, the muscle mitochondrial dysfunction was observed
independently of the key factors responsible of the laminitis
[metabolic or inflammation]. If the same dysfunction occurs in the
foot lamina, it might be possible that the ATP available to maintain the
hemidesmosome activity becomes insufficient, once the alteration of
the OXPHOS reaches a certain level, and that this would occur
independently of the etiology. In other words, a «mitochondrial
dysfunction threshold» would be reached to trigger the pathology.
To improve the comprehension of this pathophysiological
mechanism, mitochondrial respiration and ATP levels should be
studied on muscular biopsies from experimental laminitis induced by
CHO, BWE, OF administration or hyperinsulinemic/euglycemic
clamp model.
The mitochondrial function may be measured directly on lamina
biopsies obtained immediately following euthanasia when the horses
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show an OBEL 1 grade. Mitochondrial respiration may also be
measured on muscle micro-biopsies following the administration of
the triggering factor.
Since samples were obtained from clinical cases, standardization
was not possible and factors such as the time point of the micro-biopsy
related to the onset of the laminitis, the gravity of the disease, and
treatment before referral to the clinic may have influenced the results.
These factors may partly explain the wide standard deviation observed.
Conclusion
This clinical study shows for the first time a significant decrease of
muscle mitochondrial oxidative phosphorylation in horses affected by
acute laminitis when compared to the values obtained from fit or
obese healthy horses. Targeting the mitochondria in the foot should be
considered as essential for a better understanding of the
physiopathology and for new treatment strategies, with the aim to
maintain and to support the mitochondrial function before the
« mitochondrial dysfunction threshold » is reached and failure of the
dermal-epidermal interface occurs.
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